Trial
NCT03508453
IC14 for Treatment of Amyotrophic Lateral Sclerosis
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Implicit Bioscience
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
IC14
Why stopped
No participants enrolled in study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-05